Agile Therapeutics Company Profile (NASDAQ:AGRX)

About Agile Therapeutics

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of prescription contraceptive products. The Company has developed a transdermal patch technology, called Skinfusion. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drugs - Generic
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: AGRX
CUSIP:

Key Metrics:

Previous Close: $7.25
50 Day Moving Average: $7.19
200 Day Moving Average: $6.85
52-Week Range: $28,752,000.00 - $5.32
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -5.85
P/E Growth: 0.00
Market Cap: $208.45M
Outstanding Shares: 28,752,000
Beta: 2.66

Profitability:

Return on Equity: -65.65%
Return on Assets: -44.64%

Debt:

Debt-to-Equity Ratio: 0.19%
Current Ratio: 6.06%
Quick Ratio: 6.06%

Additional Links:

Companies Related to Agile Therapeutics:

Consensus Ratings for Agile Therapeutics (NASDAQ:AGRX) (?)

Ratings Breakdown:	5 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$16.60 (128.97% upside)

Analysts' Ratings History for Agile Therapeutics (NASDAQ:AGRX)

Show:

Date	Firm	Action	Rating	Price Target
8/9/2016	Noble Financial	Reiterated Rating	Buy	$15.00
6/17/2016	FBR & Co	Reiterated Rating	Buy
5/31/2016	Cantor Fitzgerald	Reiterated Rating	Buy
2/2/2016	Royal Bank Of Canada	Reiterated Rating	Outperform	$13.00 -> $15.00
11/10/2015	William Blair	Reiterated Rating	Buy	$18.00
12/30/2014	Sterne Agee CRT	Initiated Coverage	Buy

(Data available from 9/25/2014 forward)

Earnings History for Agile Therapeutics (NASDAQ:AGRX)

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
11/7/2016
8/8/2016	Q2	($0.29)	($0.29)	View	N/A
5/9/2016	Q1	($0.38)	($0.27)	View	N/A
8/13/2015		($0.37)	($0.38)	View	N/A
5/12/2015		($0.35)	($0.35)	View	N/A
3/26/2015		($0.40)	($0.37)	View	N/A
11/13/2014		($0.50)	($0.34)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Agile Therapeutics (NASDAQ:AGRX)

Current Year EPS Consensus Estimate: $-1.26 EPS
Next Year EPS Consensus Estimate: $-1.24 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	3	($0.46)	($0.30)	($0.38)
Q2 2016	2	($0.29)	($0.27)	($0.28)
Q3 2016	2	($0.34)	($0.32)	($0.33)
Q4 2016	2	($0.33)	($0.24)	($0.29)

(Data provided by Zacks Investment Research)

Dividend History for Agile Therapeutics (NASDAQ:AGRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Agile Therapeutics (NASDAQ:AGRX)

Insider Ownership Percentage: 3.50%
Institutional Ownership Percentage: 84.13%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
1/27/2016	Jay Moorin	Major Shareholder	Buy	393,700	$6.35	$2,499,995.00
6/2/2015	Alfred Altomari	CEO	Buy	2,500	$8.73	$21,825.00
1/23/2015	Jay Moorin	Major Shareholder	Buy	811,966	$5.85	$4,750,001.10
5/29/2014	Care Capital Iii Llc	Major Shareholder	Buy	500,000	$6.00	$3,000,000.00
5/23/2014	Andrew N Schiff	Director	Buy	1,333,333	$6.00	$7,999,998.00
5/22/2014	Ab Investor	Major Shareholder	Buy	1,000,000	$6.00	$6,000,000.00

(Data available from 1/1/2013 forward)

Latest Headlines for Agile Therapeutics (NASDAQ:AGRX)

Date	Headline
	3 Clinical-Stage Biotech Stocks With News About To Break (NASDAQ:AGRX) www.fool.com - September 18 at 8:10 AM
	AGILE THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial (NASDAQ:AGRX) biz.yahoo.com - August 27 at 8:09 AM
	Agile Therapeutics Reports Second Quarter 2016 Financial Results (NASDAQ:AGRX) www.pharmiweb.com - August 9 at 9:46 PM
	Agile Therapeutics : reports 2Q loss (NASDAQ:AGRX) www.4-traders.com - August 9 at 9:46 PM
	Agile Therapeutics Inc.: Agile Therapeutics Reports Second Quarter 2016 Financial Results (NASDAQ:AGRX) www.twst.com - August 9 at 9:46 PM
	Agile Therapeutics reports 2Q loss (NASDAQ:AGRX) sg.finance.yahoo.com - August 8 at 8:50 PM
	Q2 2016 Agile Therapeutics Inc Earnings Release - After Market Close (NASDAQ:AGRX) biz.yahoo.com - August 8 at 8:10 AM
	Agile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors (NASDAQ:AGRX) www.publicnow.com - July 28 at 4:18 PM
	Why Agile Therapeutics (AGRX) Stock Might be a Great Pick (NASDAQ:AGRX) finance.yahoo.com - July 21 at 8:42 AM
	SAGE On A High, JUNO Rockets As FDA Lifts Clinical Hold, FDA Panel Nod For AMGN (NASDAQ:AGRX) www.rttnews.com - July 13 at 11:26 AM
	AGILE THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:AGRX) biz.yahoo.com - July 13 at 8:32 AM
	Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline (NASDAQ:AGRX) www.publicnow.com - July 12 at 4:23 PM
	AGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stateme (NASDAQ:AGRX) biz.yahoo.com - July 6 at 4:32 PM
	Agile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer (NASDAQ:AGRX) www.publicnow.com - July 6 at 4:31 PM
	Agile Therapeutics : to Present at the Cantor Fitzgeralds 2nd Annual Healthcare Conference (NASDAQ:AGRX) www.4-traders.com - June 24 at 3:21 PM
	Agile Therapeutics to Present at the Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:AGRX) www.publicnow.com - June 23 at 4:19 PM
	Agile Therapeutics to Present at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:AGRX) finance.yahoo.com - June 23 at 4:10 PM
	8:00 am Agile Therapeutics issued patent that includes claims covering the formulation of a progestin-only transdermal patch containing levonorgestrel and is expected to expire in 2032 (NASDAQ:AGRX) finance.yahoo.com - June 16 at 8:00 AM
	Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs (NASDAQ:AGRX) finance.yahoo.com - June 16 at 8:00 AM
	AGILE THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:AGRX) biz.yahoo.com - June 8 at 4:17 PM
	Agile Therapeutics to Present at the William Blair & Company's 36th Annual Growth Stock Conference (NASDAQ:AGRX) www.publicnow.com - June 7 at 8:18 AM
	Agile Therapeutics to Present at the William Blair & Company’s 36th Annual Growth Stock Conference (NASDAQ:AGRX) finance.yahoo.com - June 7 at 8:00 AM
	Agile Therapeutics, Inc. :AGRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 (NASDAQ:AGRX) www.capitalcube.com - June 6 at 2:26 PM
	These Billionaires Just Made a Killing on Celator. Here's What Else They've Been Buying (NASDAQ:AGRX) www.fool.com - May 31 at 5:44 PM
	Can Agile Therapeutics (AGRX) Run Higher on Strong Earnings Estimate Revisions? (NASDAQ:AGRX) finance.yahoo.com - May 31 at 8:52 AM
	Agile Therapeutics (AGRX) – Investment Analysts' Weekly Ratings Updates - Let Me Know About This (NASDAQ:AGRX) www.lmkat.com - May 30 at 6:21 PM
	Stock Rating Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - HNN (NASDAQ:AGRX) hintsnewsnetwork.com - May 29 at 11:15 PM
	Caxton Corp Increased Agile Therapeutics INC (NASDAQ:AGRX) by $8.44 Million as Shares Declined - CCH Daily News (NASDAQ:AGRX) cchdailynews.com - May 28 at 6:13 PM
	Fast Moving Stocks: Agile Therapeutics, (NASDAQ:AGRX), Oracle (NYSE:ORCL), bluebird bio, (NASDAQ:BLUE ... - KC Register (NASDAQ:AGRX) www.kcregister.com - May 25 at 9:32 AM
	Earnings Review and Stock Rundown for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX) hintsnewsnetwork.com - May 25 at 9:32 AM
	Target Check and Stock Performance Recap Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX) hintsnewsnetwork.com - May 24 at 6:23 PM
	Stock Rating Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX) hintsnewsnetwork.com - May 22 at 10:51 PM
	Latest Analyst Ratings For Agile Therapeutics, Inc. (AGRX) - Share Trading News (NASDAQ:AGRX) www.sharetrading.news - May 20 at 9:50 AM
	Share Recap and Earnings Focus on Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX) hintsnewsnetwork.com - May 18 at 6:17 PM
	Share Performance and Target Price Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX) hintsnewsnetwork.com - May 17 at 11:15 PM
	AGILE THERAPEUTICS INC Financials (NASDAQ:AGRX) finance.yahoo.com - May 17 at 1:04 PM
	Consensus Rating Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX) hintsnewsnetwork.com - May 16 at 6:02 PM
	Morning Watch List:Agile Therapeutics, Inc. (NASDAQ:AGRX), Winthrop Realty Trust (NYSE:FUR), Facebook Inc ... - KC Register (NASDAQ:AGRX) www.kcregister.com - May 12 at 6:38 PM
	Agile Therapeutics Inc (AGRX) Rating Reiterated by FBR & Co. - Washington News Wire (NASDAQ:AGRX) washingtonnewswire.com - May 11 at 4:50 AM
	Performance Recap and Target Perspective on Agile Therapeutics, Inc. (NASDAQ:AGRX) - B.O.D.Y Confidential (NASDAQ:AGRX) www.bodyconfidential.com - May 10 at 4:47 AM
	Agile Therapeutics reports 1Q loss (NASDAQ:AGRX) sg.finance.yahoo.com - May 9 at 6:18 PM
	Agile Therapeutics Reports First Quarter 2016 Financial Results (NASDAQ:AGRX) www.publicnow.com - May 9 at 4:28 PM
	Q1 2016 Agile Therapeutics Inc Earnings Release - After Market Close (NASDAQ:AGRX) biz.yahoo.com - May 9 at 7:07 AM
	Earnings Outlook on Agile Therapeutics, Inc. (NASDAQ:AGRX) - B.O.D.Y Confidential (NASDAQ:AGRX) www.bodyconfidential.com - May 4 at 11:41 PM
	Average Analyst Rating for Agile Therapeutics, Inc. (NASDAQ:AGRX) - B.O.D.Y Confidential (NASDAQ:AGRX) www.bodyconfidential.com - May 2 at 6:54 PM
	Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference (NASDAQ:AGRX) www.publicnow.com - March 30 at 4:21 PM
	Agile Therapeutics reports 4Q loss (NASDAQ:AGRX) sg.finance.yahoo.com - March 9 at 5:09 PM
	Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results (NASDAQ:AGRX) finance.yahoo.com - March 9 at 4:10 PM
	Agile Therapeutics to Present at the 28th Annual ROTH Conference (NASDAQ:AGRX) finance.yahoo.com - March 3 at 4:15 PM
	AGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Finan (NASDAQ:AGRX) biz.yahoo.com - February 24 at 4:22 PM